Application of LC–MS/MS Method for Determination of Dihydroartemisin in Human Plasma in a Pharmacokinetic Study
- 29 October 2020
- journal article
- research article
- Published by Taylor & Francis in Bioanalysis
- Vol. 12 (22) , 1635-1646
Abstract
Aim: Dihydroartemisinin (DHA) was also found therapeutic potential for the treatment of systemic lupus erythematosus (SLE). To assess the pharmacokinetic profile of DHA, the concentration of DHA in...Keywords
Funding Information
- Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs (2016-I2M-1-010)
- Chinese National Major Project for New Drug Innovation (2019ZX09734001)
- Drug Development and Application of Chinese Pharmacological Society (2019DL001)
- Jinqiao Project of Beijing Association of Science and Technology (ZZ19005)
This publication has 18 references indexed in Scilit:
- Monitoring of Artemisinin, Dihydroartemisinin, and Artemether in Environmental Matrices Using High-Performance Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)Journal of Agricultural and Food Chemistry, 2011
- Development and validation of a liquid chromatography and ion spray tandem mass spectrometry method for the quantification of artesunate, artemether and their major metabolites dihydroartemisinin and dihydroartemisinin‐glucuronide in sheep plasmaJournal of Mass Spectrometry, 2011
- Systematic LC‐MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought‐out chromatographyBiomedical Chromatography, 2009
- Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2009
- Validation of high performance liquid chromatography–electrochemical detection methods with simultaneous extraction procedure for the determination of artesunate, dihydroartemisinin, amodiaquine and desethylamodiaquine in human plasma for application in clinical pharmacological studies of artesunate–amodiaquine drug combinationJournal of Chromatography B, 2009
- A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasmaJournal of Chromatography B, 2008
- Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studiesJournal of Chromatography B, 2008
- Pharmacokinetics of dihydroartemisinin in Artekin tablets for single and repeated dosing in Chinese healthy volunteersBiopharmaceutics & Drug Disposition, 2008
- Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocationInternational Immunopharmacology, 2006
- An HPLC‐MS method for simultaneous estimation of α,β‐arteether and its metabolite dihydroartemisinin, in rat plasma for application to pharmacokinetic studyBiomedical Chromatography, 2003